File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Response to Wang et al. Re: How to choose and compare between radiofrequency ablation and transarterial chemoembolization for recurrent hepatocellular carcinoma?

TitleResponse to Wang et al. Re: How to choose and compare between radiofrequency ablation and transarterial chemoembolization for recurrent hepatocellular carcinoma?
Authors
Issue Date2017
PublisherElsevier Ltd. The Journal's web site is located at http://www.hpbonline.org/
Citation
HPB, 2017, v. 19 n. 12, p. 1133 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/259551
ISSN
2021 Impact Factor: 3.842
2020 SCImago Journal Rankings: 1.577
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorKoh, PS-
dc.contributor.authorChan, ACY-
dc.date.accessioned2018-09-03T04:09:48Z-
dc.date.available2018-09-03T04:09:48Z-
dc.date.issued2017-
dc.identifier.citationHPB, 2017, v. 19 n. 12, p. 1133-
dc.identifier.issn1365-182X-
dc.identifier.urihttp://hdl.handle.net/10722/259551-
dc.languageeng-
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.hpbonline.org/-
dc.relation.ispartofHPB-
dc.titleResponse to Wang et al. Re: How to choose and compare between radiofrequency ablation and transarterial chemoembolization for recurrent hepatocellular carcinoma?-
dc.typeArticle-
dc.identifier.emailChan, ACY: acchan@hku.hk-
dc.identifier.authorityChan, ACY=rp00310-
dc.identifier.doi10.1016/j.hpb.2017.08.007-
dc.identifier.scopuseid_2-s2.0-85029657684-
dc.identifier.hkuros288819-
dc.identifier.volume19-
dc.identifier.issue12-
dc.identifier.spage1133-
dc.identifier.epage1133-
dc.identifier.isiWOS:000416442700015-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1365-182X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats